Amino acid starvation induces reactivation of silenced transgenes and latent HIV-1 provirus via down-regulation of histone deacetylase 4 (HDAC4)
暂无分享,去创建一个
A. Mai | R. Piccirillo | G. Casari | S. Valente | F. Boneschi | P. Brambilla | M. Riba | G. Poli | Giulia Della Chiara | I. Palmisano | Claudia H. Huichalaf | M. V. Schiaffino | Silvia Corbetta | D. Gabellini | R. L. D'Ambrosio | R. L. D’Ambrosio
[1] S. Deeks. HIV: Shock and kill , 2012, Nature.
[2] M. Giacca,et al. Negative regulation of HIV-1 transcription by a heterodimeric NF-κB1/p50 and C-terminally truncated STAT5 complex. , 2011, Journal of molecular biology.
[3] S. Lewin,et al. HIV cure and eradication: how will we get from the laboratory to effective clinical trials? , 2011, AIDS.
[4] B. Aronow,et al. Modulation of chromatin position and gene expression by HDAC4 interaction with nucleoporins , 2011, The Journal of cell biology.
[5] K. Benabdellah,et al. Physiological and tissue-specific vectors for treatment of inherited diseases , 2011, Gene Therapy.
[6] E. Verdin,et al. Epigenetic regulation of HIV latency , 2011, Current opinion in HIV and AIDS.
[7] D. Margolis,et al. Histone deacetylase inhibitors and HIV latency , 2011, Current opinion in HIV and AIDS.
[8] S. Zeichner,et al. Cell line-dependent variability in HIV activation employing DNMT inhibitors , 2010, Virology Journal.
[9] H. Virgin,et al. Histone Deacetylases and the Nuclear Receptor Corepressor Regulate Lytic-Latent Switch Gene 50 in Murine Gammaherpesvirus 68-Infected Macrophages , 2010, Journal of Virology.
[10] Su-Ju Lin,et al. Regulation of yeast sirtuins by NAD(+) metabolism and calorie restriction. , 2010, Biochimica et biophysica acta.
[11] C. Van Lint,et al. HIV Persistence and the Prospect of Long-Term Drug-Free Remissions for HIV-Infected Individuals , 2010, Science.
[12] A. Mai,et al. Histone deacetylase inhibitors: keeping momentum for neuromuscular and cardiovascular diseases treatment. , 2010, Pharmacological research.
[13] D. Reinberg,et al. Chromatin structure and the inheritance of epigenetic information , 2010, Nature Reviews Genetics.
[14] Sung Soon Kim,et al. Novel histone deacetylase inhibitors CG05 and CG06 effectively reactivate latently infected HIV-1 , 2010, AIDS.
[15] A. Mai,et al. Histone deacetylase inhibitors and neurodegenerative disorders: holding the promise. , 2009, Current pharmaceutical design.
[16] D. Sabatini,et al. mTOR signaling at a glance , 2009, Journal of Cell Science.
[17] Arsène Burny,et al. Synergistic Activation of HIV-1 Expression by Deacetylase Inhibitors and Prostratin: Implications for Treatment of Latent Infection , 2009, PloS one.
[18] H. Prince,et al. Clinical Studies of Histone Deacetylase Inhibitors , 2009, Clinical Cancer Research.
[19] D. Hazuda,et al. The Challenge of Finding a Cure for HIV Infection , 2009, Science.
[20] Amy S. Espeseth,et al. Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid. , 2009, AIDS research and human retroviruses.
[21] V. Castronovo,et al. HDAC4 represses p21WAF1/Cip1 expression in human cancer cells through a Sp1-dependent, p53-independent mechanism , 2009, Oncogene.
[22] A. Kozikowski,et al. Use of the nitrile oxide cycloaddition (NOC) reaction for molecular probe generation: a new class of enzyme selective histone deacetylase inhibitors (HDACIs) showing picomolar activity at HDAC6. , 2008, Journal of medicinal chemistry.
[23] A. Ballabio,et al. The ocular albinism type 1 protein, an intracellular G protein-coupled receptor, regulates melanosome transport in pigment cells , 2008, Human molecular genetics.
[24] C. Decatur,et al. L-DOPA Is an Endogenous Ligand for OA1 , 2008, PLoS biology.
[25] T. Ghosh,et al. Demethylation of (Cytosine-5-C-methyl) DNA and regulation of transcription in the epigenetic pathways of cancer development , 2008, Cancer and Metastasis Reviews.
[26] Guoping Feng,et al. The Histone Deacetylase HDAC4 Connects Neural Activity to Muscle Transcriptional Reprogramming* , 2007, Journal of Biological Chemistry.
[27] Liang Da,et al. CpG methylation plays a vital role in determining tissue- and cell-specific expression of the human cell-death-inducing DFF45-like effector A gene through the regulation of Sp1/Sp3 binding , 2007, Nucleic acids research.
[28] U. Koch,et al. Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases , 2007, Proceedings of the National Academy of Sciences.
[29] F. Dequiedt,et al. Recruitment of chromatin‐modifying enzymes by CTIP2 promotes HIV‐1 transcriptional silencing , 2007, The EMBO journal.
[30] Richard A Young,et al. Chromatin immunoprecipitation and microarray-based analysis of protein location , 2006, Nature Protocols.
[31] Satoshi Inoue,et al. Inhibition of histone deacetylase class I but not class II is critical for the sensitization of leukemic cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. , 2006, Cancer research.
[32] R. Piccirillo,et al. An unconventional dileucine-based motif and a novel cytosolic motif are required for the lysosomal and melanosomal targeting of OA1 , 2006, Journal of Cell Science.
[33] Cheryl Jennings,et al. Depletion of latent HIV-1 infection in vivo: a proof-of-concept study , 2005, The Lancet.
[34] Hong Chen,et al. Nutritional control of gene expression: how mammalian cells respond to amino acid limitation. , 2005, Annual review of nutrition.
[35] L. Altucci,et al. Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides. , 2005, Journal of medicinal chemistry.
[36] John M. Shelton,et al. Histone Deacetylase 4 Controls Chondrocyte Hypertrophy during Skeletogenesis , 2004, Cell.
[37] C. Van Lint,et al. Administration of HDAC inhibitors to reactivate HIV-1 expression in latent cellular reservoirs: implications for the development of therapeutic strategies. , 2004, Biochemical pharmacology.
[38] M. Giacca,et al. Regulation of HIV‐1 gene expression by histone acetylation and factor recruitment at the LTR promoter , 2003, The EMBO journal.
[39] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[40] M. Pfaffl,et al. A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.
[41] E. Vicenzi,et al. Envelope-Dependent Restriction of Human Immunodeficiency Virus Type 1 Spreading in CD4+ T Lymphocytes: R5 but Not X4 Viruses Replicate in the Absence of T-Cell Receptor Restimulation , 1999, Journal of Virology.
[42] A. Ballabio,et al. Ocular albinism: evidence for a defect in an intracellular signal transduction system , 1999, Nature Genetics.
[43] R Brookmeyer,et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. , 1997, Science.
[44] A. Ballabio,et al. The ocular albinism type 1 gene product is a membrane glycoprotein localized to melanosomes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[45] Minoru Yoshida,et al. [Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A]. , 1990, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.
[46] A. Fauci,et al. Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines. , 1989, Science.
[47] A. Fauci,et al. Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. , 1989, Journal of immunology.
[48] J. Justement,et al. Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. , 1988, Journal of immunology.
[49] R. Gallo,et al. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. , 1984, Science.
[50] J. Chermann,et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). , 1983, Science.
[51] E. Olson,et al. The many roles of histone deacetylases in development and physiology: implications for disease and therapy , 2009, Nature Reviews Genetics.
[52] L. Altucci,et al. "Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence. , 2009, Retrovirology.
[53] F. Dequiedt,et al. Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. , 2002, Molecular cell.